Latest News
HIG Growth Partners’ portfolio company, Community Intervention Services, has completed the acquisition of Family Behavioral Resources (FBR).
CIS was established by HIG in partnership with veteran behavioural healthcare executive Kevin Sheehan to acquire, develop and operate a national network of community-based mental health and substance abuse treatment programmes.
FBR marks CIS’s third acquisition and provides the company with a strong regional presence in the Mid-Atlantic and a beachhead into the Midwest.
Headquartered in Greensburg, Pennsylvania, FBR was founded in 1999 and has since grown into a leading provider of community-based outpatient behavioural health services delivered primarily in the patient’s natural
Baker & McKenzie has released its 2013 Insights report, an in-depth look at some of the key trends and developments in the global private equity industry.
With contributions from EQT, Platinum Equity, A Capital, AXA Private Equity, Carlyle, CVCI and many other industry commentators from around the world, Insights profiles some of the successful strategies currently being employed by funds, investors, management and companies.
Simon Hughes, global chair of Baker & McKenzie’s private equity group, says: "Private equity and infrastructure funds that are adaptable and maintain a wide field of vision, are continuing to discover excellent investment opportunities. This report
Activa Capital has sold its portfolio company Logitrade to a group of regional financial investors – Soridec, Sofilaro, Sofipac, Multicroissance and Sopromec – in partnership with Logitrade’s management team.
Activa Capital became the majority shareholder of Logitrade in 2006.
Logitrade is an outsourcing company focused on non-strategic industrial purchasing in France.
Under Activa Capital’s ownership, Logitrade experienced a growth in its turnover from EUR85m in 2006 to EUR140m in 2012. In the recent years, the company has also strengthened its international presence, accompanying its large industrial customers outside France.
The offshore markets experienced their largest quarter-to-quarter rise in M&A transactions in the last three years in quarter four 2012, according to a report by Appleby.
The latest edition of Offshore-i, the firm’s quarterly report which provides data and insight on merger and acquisition activity in major offshore financial centres, focuses on the last three months of 2012 while providing a review of the year as a whole and predictions for 2013.
Both the volume and value of deals involving offshore targets increased considerably in Q4 as against the preceding three months, with volume up 27 per cent and value
Cayman Finance has issued a statement regarding the US Senate Finance Commission confirmation hearing of Jack Lew…
At the recent United States (US) Senate Finance Committee confirmation hearing Mr Jack Lew, President Obama’s nominee for Treasury Secretary, was asked about his investment in a Cayman Islands (Cayman) investment fund domiciled in Ugland House.
At this juncture, it is perhaps worth asking why people are still surprised that Americans including both Republicans and Democrats have money invested in Cayman investment funds, when it is certainly the case that all Americans who have a pension fund will likely have their money
Pan-emerging makers private equity firm Actis has appointed Sergio Brandao as a director focusing on energy opportunities in Latin America.
Brandao (pictured) will be based in Actis’s São Paulo office, where the firm now has a team of 12 investment professionals focusing on the consumer, financial services and energy sectors.
Barndao joins Actis from Rio Bravo Investimentos where he was partner and co-fund manager. Prior to that he worked at Skanska, Unocal and the AES Corporation, and for a decade at Royal Dutch Shell in the US, UK, the Netherlands and Brunei.
Actis has recently made a number of
The Employee Stock Option Fund (ESO Fund), a specialist in stock option financing for employees of venture-backed companies, has appointed Michael Banks as a venture partner.
Banks (pictured) is the founding partner of Windy Hill Capital, a seed capital fund, and has spent the last 16 years with leading venture firms investing in entrepreneurs at compelling technology companies like Pure Digital Technologies, Peregrine Semiconductor, Tapjoy, Silverpop and Kanjoya.
"As a board member of a variety of successful start-ups, I became aware that many departing employees were struggling financially to exercise their vested equity positions. As an investor, I saw the
LINC Scotland members invested GBP13.76m into Scottish early-stage companies in 2012 – a 13 per cent increase in investment on the previous year.
Figures published by LINC Scotland, the national association for business angels in Scotland, show that the amount invested in new companies increased by 54 per cent last year, its members and other private investors completed 82 investments (up five per cent), and helped 59 companies (also up five per cent). Of these over a third were new to the portfolio, up from less than a quarter in 2011.
Although the total value of investment raised was
HYCOR Biomedical, Inc (HYCOR), a leading manufacturer and marketer of in vitro diagnostic products for the global allergy and autoimmune markets, has sold its urinalysis business to an affiliate of One Rock Capital Partners, Laurel Crown Partners, and StoneCreek Capital. The sale includes the KOVA® system of urinalysis products. HYCOR is a portfolio company of Linden Capital Partners (Linden).
“The divestiture of the urinalysis business represents an important step in our growth strategy for HYCOR and allows us to focus exclusively on the growing, global allergy and autoimmune sectors of in vitro diagnostics,” says Richard Novak, Chairman of HYCOR’s Board of
Osprey Capital, the venture capital firm, has exited its first investment following the sale of Allium Capital, with a return of 11.9x capital for investors. The investment in Allium Capital, a specialist advisory firm which creates and distributes retail financial services products, was made four years ago.
During this time the firm has grown assets to over GBP400m with the sale generating significant returns for investors.
Ronan Kearney (pictured), chairman, Osprey Capital, says: “Allium Capital was an excellent investment for Osprey Capital and has shown significant growth in the past four years. It is pleasing to see such a strong
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
